^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Endometrial carcinoma: Preferred regimens…Carboplatin/paclitaxel (category 1 for carcinosarcoma)
